Robert Yu

Robert T. Yu is a prominent scientist in the field of process and discovery chemistry, currently serving as the Associate Director of Chemical Development Drug Substance MS&T at Deciphera Pharmaceuticals since May 2023. Prior to this role, he held various positions at C4 Therapeutics, Inc., including Senior Research Scientist I in Process & Discovery Chemistry from May 2019 to July 2021, and later as Senior Research Scientist II until March 2023.1

Education and Early Career

Yu earned his Bachelor of Science degree in Chemistry from the University of California, Berkeley (1997-2001) and completed his Ph.D. in Organic Chemistry at Colorado State University (2003-2008). His doctoral research was supervised by Professor Tomislav Rovis. Following his Ph.D., he worked as a postdoctoral researcher at Harvard University under Professor Andrew G. Myers from January 2009 to May 2011.1

Professional Experience

Before joining C4 Therapeutics, Yu worked at Eisai US, where he progressed through roles from Scientist in Process Research to Senior Scientist in Integrated Chemistry over a span of nearly eight years (2011-2019). His experience also includes a research associate position at Roche Pharmaceuticals.13

Contributions and Expertise

Yu's work primarily focuses on drug development processes, particularly in optimizing chemical processes for therapeutic compounds. His expertise is crucial in advancing the development of novel cancer therapies, particularly those targeting RAS mutations, which are significant in various cancers.2 His contributions to the field are reflected in his leadership roles and his involvement in cutting-edge research within the pharmaceutical industry.

Current Role

As of now, Robert Yu continues to leverage his extensive background in chemistry and drug development to lead initiatives that aim to enhance therapeutic efficacy and streamline chemical processes at Deciphera Pharmaceuticals.1